• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
LB Pharmaceuticals released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1405 (forecast USD -0.57)
04:00
LB Pharmaceuticals released FY2025 9 Months Earnings on November 6, 2025 (EST) with actual revenue of USD 0 and EPS of USD -40.5593
04:00
Oct6
LB Pharmaceuticals' LB-102 Earns Buy Rating, Shows Great Potential
14:07
Sep16
Pontifax Management 4 G.P. (2015) Ltd. Announced Acquisition of LB Pharmaceuticals Inc. Common Stock
20:16
Aug23
LB Pharmaceuticals released FY2025 Semi-Annual earnings on August 22 (EST), actual revenue USD 0, actual EPS USD -40.4187
03:00
LB Pharmaceuticals released FY2025 Q1 earnings on August 22 (EST), actual revenue USD 0, actual EPS USD -20.2093
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.556 M, EPS -0.1405

Sep11
IPO(EST)

Listing Price USD 15

Aug22
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.089 M, EPS -20.2093

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More